Ovid Therapeutics Inc. Lessee, Operating Lease, Liability, to be Paid, Year One
Ovid Therapeutics Inc. (OVID) had Lessee, Operating Lease, Liability, to be Paid, Year One of $2.32 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Commitment and Contingencies › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths · last filed 2026-08-13
- 2026-06-30: Lessee, Operating Lease, Liability, to be Paid, Year One $2.32M.
- 2026-03-31: Lessee, Operating Lease, Liability, to be Paid, Year One $2.32M.
- 2025-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $2.32M.
- 2025-09-30: Lessee, Operating Lease, Liability, to be Paid, Year One $2.32M.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year One |
|---|---|
| 2026-06-30 | $2.32M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $2.32M 10-Q · filed 2026-05-12 |
| 2025-12-31 | $2.32M 10-K · filed 2026-03-18 |
| 2025-09-30 | $2.32M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $2.32M 10-Q · filed 2025-08-13 |
| 2025-03-31 | $2.32M 10-Q · filed 2025-05-13 |
| 2024-12-31 | $2.32M 10-K · filed 2025-03-11 |
| 2024-09-30 | $2.32M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $2.32M 10-Q · filed 2024-08-13 |
| 2024-03-31 | $2.32M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $2.32M 10-K · filed 2024-03-08 |
| 2023-09-30 | $2.32M 10-Q · filed 2023-11-03 |
| 2023-06-30 | $2.32M 10-Q · filed 2023-08-04 |
| 2023-03-31 | $2.32M 10-Q · filed 2023-05-05 |
| 2022-12-31 | $1.67M 10-K · filed 2023-03-13 |
| 2022-09-30 | $1.67M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $1.67M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $1.87M 10-Q · filed 2022-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B |